Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion type Assertion NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_head.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion description "[Importantly, PEAK1 inactivation sensitized PDAC cells to trastuzumab and gemcitabine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_provenance.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion evidence source_evidence_literature NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_provenance.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion SIO_000772 22589274 NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_provenance.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion wasDerivedFrom befree-2016 NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_provenance.
- NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_assertion wasGeneratedBy ECO_0000203 NP982595.RA0wrpZtBiEVEMccY2cgA4fE1F22MZ2byf2kFWIN4rM1g130_provenance.